This collection of Nature Publishing Group articles highlights the various medical conditions that make up what is commonly referred to as Metabolic Syndrome.

Metabolic syndrome affects nearly 50 million Americans — almost one in four American adults. Approximately seven percent of adults in their 20s and about 40 percent of adults over 40 meet the criteria for the syndrome. Metabolic syndrome is a cluster of conditions that occur together and increase the risk for heart disease, stroke and diabetes. Having just one of these conditions — increased blood pressure, elevated insulin levels, excess body fat around the waist or abnormal cholesterol levels — contributes to the risk of serious disease and in combination, the risk is even greater.

There is no accepted or official definition of metabolic syndrome. Whether these risk factors actually can be referred to as a syndrome or not, they represent a growing medical condition involving multiple medical specialties.

This free collection provides valuable insight into this emerging medical and public health epidemic.



American Journal of Hypertension

Metabolic syndrome: comparison of the two commonly used animal models

M Oron-Herman, Y Kamari, E Grossman, G Yeger, E Peleg, Z Shabtay, A Shamiss, Y Sharabi

doi: 10.1038/ajh.2008.218

American Journal of Hypertension 21, 1018-1022 (19 June 2008)

Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong cardiovascular risk factor prevalence study-2 (CRISPS2)

B M Y Cheung, N M S Wat, Y B Man, S Tam, C H Cheng, G M Leung, J Woo, E D Janus, C P Lau, T H Lam, K S L Lam

doi:10.1038/ajh.2007.19

American Journal of Hypertension 21, 17-22 (January 2008)

European Journal of Clinical Nutrition

Coffee consumption, serum [gamma]-glutamyltransferase and risk of type II diabetes

S Bidel, K Silventoinen, G Hu, D-H Lee, J Kaprio, J Tuomilehto

doi:10.1038/sj.ejcn.1602712

European Journal of Clinical Nutrition 62, 178 - 185 (07 Mar 2007)

The associations between current recommendation for physical activity and cardiovascular risks associated with obesity

M Akbartabartoori, M E J Lean, C R Hankey

doi:10.1038/sj.ejcn.1602693

European Journal of Clinical Nutrition 62, 1 - 9 (07 Mar 2007)

Top

International Journal of Impotence Research

Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome

M Baumhäkel, N Schlimmer, M Böhm

doi:10.1038/ijir.2008.28

International Journal of Impotence Research 20, 493-500 (2008)

Obesity and sexual dysfunction, male and female

K Esposito, F Giugliano, M Ciotola, M De Sio, M D'Armiento, D Giugliano

doi:10.1038/ijir.2008.9

International Journal of Impotence Research 20, 358 - 365 (10 Apr 2008)

Top

International Journal of Obesity

Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus

G R C Zilverschoon, C J Tack, L A B Joosten, B J Kullberg, J W M van der Meer, M G Netea

doi:10.1038/ijo.2008.109

International Journal of Obesity 32, 1407-1414 (22 Jul 2008)

Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study

C M Ballantyne, R C Hoogeveen, A M McNeill, G Heiss, M I Schmidt, B B Duncan, J S Pankow

doi:10.1038/ijo.2008.109

International Journal of Obesity 32, S21 - S24 (12 May 2008)

Top

Journal of Human Hypertension

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients

A L M Vlek, Y van der Graaf, W Spiering, F L J Visseren

doi:10.1038/jhh.2008.5

Journal of Human Hypertension 22, 358 - 365 (14 Feb 2008)

Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension

E Teijeira-Fernandez, S Eiras, L Grigorian-Shamagian, A Fernandez, B Adrio, J R Gonzalez-Juanatey

doi:10.1038/jhh.2008.75

Journal of Human Hypertension (24 Jul 2008)

Top

Nature Clinical Practice Cardiovascular Medicine

Play an ADAGIO with a STRADIVARIUS: the right patient for CB1 receptor antagonists?

V Di Marzo

doi:10.1038/ncpcardio1319

Nature Clinical Practice Cardiovascular Medicine 5, 610-612 (August 2008)

Older age should not be a barrier to the treatment of hypertension

W S Aronow

doi:10.1038/ncpcardio1291

Nature Clinical Practice Cardiovascular Medicine 5, 514-515 (July 2008)

Top

Nature Clinical Practice Endocrinology and Metabolism

The metabolic syndrome: progress towards one definition for an epidemic of our time

P Zimmet and G Alberti

doi:10.1038/ncpendmet0834

Nature Clinical Practice Endocrinology and Metabolism 4, 239 (May 2008)

Cardiometabolic features of polycystic ovary syndrome

L K Hoffman and D A Ehrmann

doi:10.1038/ncpendmet0755

Nature Clinical Practice Endocrinology and Metabolism 4, 215-222 (May 2008)

Top

Obesity

Influence of age on the association of retinol-binding protein 4 With metabolic syndrome

S Gavi, S Qurashi, L M Stuart, R Lau, M M Melendez, D C Mynarcik, M A McNurlan and M C Gelato

doi:10.1038/oby.2007.138

Obesity 16, 893-895 (April 2008)

Genome-wide linkage scan for the metabolic syndrome: the GENNID study

K L Edwards, C M Hutter, J Y Wan, H Kim and S A Monks

doi:10.1038/oby.2008.236

Obesity 16, 1596-1601 (July 2008)

Extra navigation

naturejobs

natureproducts


Advertisement